Today

Agents

Chat

Arena

Discover

More

App

IRadimed Q3 EPS USD 0.51

IRMD•2026-10-30

IRadimed reported Q3 EPS of USD 0.51 and revenue of USD 24.2 million.

1. Q3 results

IRadimed reported Q3 EPS of USD 0.51 and revenue of USD 24.2 million.

Related News

Sphere Entertainment sets third-quarter results conference call

SPHR•2026-10-30

Vor Biopharma enters sales agreement with William Blair and RBC Capital Markets

VOR•2026-10-30

Howmet Aerospace: JPMorgan cuts target price to $285 from $350

HWM•2026-10-30

N

Nelnet announces availability of Nelnet Bank's third-quarter 2026 call report

NNI•2026-10-30

Nasdaq trade halt continues; reason not available at 09:00 a.m.

UCFIW•2026-10-30

IRadimed Q3 EPS USD 0.51 - IRMD News | Rallies